The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care.
This marks the first time the Committee has formally partnered with an industry participant. The collaboration will focus on cutting-edge neurosurgical technologies, advanced medical imaging, global training and knowledge-sharing initiatives to improve patient outcomes worldwide. Both organizations aim to set a new benchmark for ethical, innovation-led partnerships in global neurosurgical care.
Commenting on the partnership, Prof. Dr. Iype Cherian, Chairperson of the WFNS Innovation & Technology Committee, said, “For the first time in the history of the WFNS Innovation Committee, we are opening our doors to the private sector. This partnership reflects our commitment to bringing together the most innovative minds and transformative technologies to advance neurosurgical care globally. Time Medical International Ventures has demonstrated exceptional capabilities in innovation and clinical technology, making them an ideal partner as we work collectively to shape the future of neurosurgery.”
He further added, “This collaboration will help champion the development and global dissemination of cutting-edge neurosurgical solutions, facilitate knowledge exchange between leading neurosurgeons and industry experts, and support training and technology transfer initiatives in emerging markets. We believe this partnership will set a new benchmark for industry collaboration within global neurosurgical governance.”
Speaking on the association, Svetlana Rao, Director of Time Medical International Ventures (India) Pvt. Ltd., said, “This collaboration represents a shared vision of advancing neurosurgical excellence through innovation, technology, and global cooperation. As a wholly owned subsidiary of Fischer Medical Ventures Limited, we remain committed to supporting transformative healthcare solutions that improve accessibility, precision, and patient outcomes across diverse healthcare systems.”
The WFNS Innovation & Technology Committee expressed confidence that this landmark partnership will set a new benchmark for industry’s role in global neurosurgical governance and serve as a model for future collaborations. The Committee reaffirmed its commitment to ensuring that the engagement remains impactful, transparent, and guided by the highest ethical standards.
